Rossari Biotech Ltd
NSE:ROSSARI

Watchlist Manager
Rossari Biotech Ltd Logo
Rossari Biotech Ltd
NSE:ROSSARI
Watchlist
Price: 499.1 INR 2.14% Market Closed
Market Cap: ₹27.6B

Wall St Price Targets

ROSSARI Price Targets Summary
Rossari Biotech Ltd

Wall Street analysts forecast ROSSARI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ROSSARI is 613.79 INR with a low forecast of 575.7 INR and a high forecast of 668.85 INR.

Lowest Forecast
Price Target
575.7 INR
15% Upside
Average Forecast
Price Target
613.79 INR
23% Upside
Highest Forecast
Price Target
668.85 INR
34% Upside
Rossari Biotech Ltd Competitors:
Price Targets
SMWB
Similarweb Ltd
64% Upside

Revenue
Forecast

31% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
31% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 3 years is 13%.

Gross Profit
Forecast

33% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
33% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 33%. The projected CAGR for the next 3 years is 13%.

Operating Income
Forecast

32% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
32% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 8 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 3 years is 15%.

Pre-Tax Income
Forecast

33% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
33% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

33% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
33% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Net Income has been 33%. The projected CAGR for the next 3 years is 13%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ROSSARI's stock price target?
Price Target
613.79 INR

According to Wall Street analysts, the average 1-year price target for ROSSARI is 613.79 INR with a low forecast of 575.7 INR and a high forecast of 668.85 INR.

What is the Revenue forecast for Rossari Biotech Ltd?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Revenue has been 31%. The projected CAGR for the next 3 years is 13%.

What is the Gross Profit forecast for Rossari Biotech Ltd?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 33%. The projected CAGR for the next 3 years is 13%.

What is the Operating Income forecast for Rossari Biotech Ltd?
Projected CAGR
15%

Over the last 8 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 3 years is 15%.

What is the Pre-Tax Income forecast for Rossari Biotech Ltd?
Projected CAGR
12%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Rossari Biotech Ltd?
Projected CAGR
13%

Over the last 8 years, the compound annual growth rate for Net Income has been 33%. The projected CAGR for the next 3 years is 13%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett